Kresken, M.; Pfeifer, Y.; Wagenlehner, F.; Werner, G.; Wohlfarth, E.; Therapy, o.b.o.S.G.‘A.R.o.t.P.E.S.f.I.
Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20. Antibiotics 2022, 11, 751.
https://doi.org/10.3390/antibiotics11060751
AMA Style
Kresken M, Pfeifer Y, Wagenlehner F, Werner G, Wohlfarth E, Therapy oboSG‘ARotPESfI.
Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20. Antibiotics. 2022; 11(6):751.
https://doi.org/10.3390/antibiotics11060751
Chicago/Turabian Style
Kresken, Michael, Yvonne Pfeifer, Florian Wagenlehner, Guido Werner, Esther Wohlfarth, and on behalf of Study Group ‘Antimicrobial Resistance‘ of the Paul Ehrlich Society for Infection Therapy.
2022. "Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20" Antibiotics 11, no. 6: 751.
https://doi.org/10.3390/antibiotics11060751
APA Style
Kresken, M., Pfeifer, Y., Wagenlehner, F., Werner, G., Wohlfarth, E., & Therapy, o. b. o. S. G. ‘A. R. o. t. P. E. S. f. I.
(2022). Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20. Antibiotics, 11(6), 751.
https://doi.org/10.3390/antibiotics11060751